Responses
Clinical and epidemiological research
Extended report
A phase III, multicentre, randomised, double-blind, active-controlled, parallel-group trial comparing safety and efficacy of HD203, with innovator etanercept, in combination with methotrexate, in patients with rheumatoid arthritis: the HERA study
Compose a Response to This Article
Other responses
No responses have been published for this article.